Masimo says Apple to remove sensor from Watch to avoid U.S. ban, WSJ reports

Apple (AAPL) is removing a blood-oxygen sensor from certain models of its smartwatches to get around a patent dispute related to the technology, according to a Masimo (MASI) filing on Monday, reported The Wall Street Journal’s Aaron Tilley. Last month, a U.S. import ban went into effect following an October ruling by the U.S. International Trade Commission, which found Apple had violated the patents of medical-technology company Masimo, and while the removal of the technology may clear the path for uninterrupted future sales, Apple’s legal troubles with Masimo highlight the perils of Apple’s entry into the health market, according to The Journal.